United Therapeutics CorpNASDAQ:UTHR
- LAST PRICE264.2700
- TODAY'S CHANGE (%)-1.7800 (-0.6690%)
- Bid / Lots240.0000/ 6
- Ask / Lots274.8300/ 1
- Open / Previous Close266.0000 / 266.0500
- Day Range
- 52 Week Range
- Volume391,702
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | UTHR |
|---|---|---|
| 09:32 ET | 2138 | 266 |
| 09:34 ET | 100 | 266.425 |
| 09:36 ET | 400 | 266.39 |
| 09:43 ET | 200 | 266.86 |
| 09:45 ET | 300 | 266.86 |
| 09:52 ET | 900 | 267.14 |
| 09:54 ET | 1504 | 267.05 |
| 09:56 ET | 2148 | 266.98 |
| 09:57 ET | 600 | 267.065 |
| 10:01 ET | 100 | 266.985 |
| 10:03 ET | 300 | 267.925 |
| 10:06 ET | 1928 | 267.98 |
| 10:08 ET | 583 | 268.11 |
| 10:10 ET | 3318 | 268.45 |
| 10:12 ET | 200 | 268.72 |
| 10:14 ET | 1300 | 269.085 |
| 10:15 ET | 9430 | 269.15 |
| 10:17 ET | 1802 | 269.13 |
| 10:19 ET | 300 | 269.35 |
| 10:21 ET | 300 | 269.68 |
| 10:24 ET | 400 | 269.6989 |
| 10:26 ET | 1650 | 269.035 |
| 10:28 ET | 631 | 268.43 |
| 10:30 ET | 200 | 267.95 |
| 10:33 ET | 307 | 267.7 |
| 10:35 ET | 190 | 267.685 |
| 10:37 ET | 100 | 268.13 |
| 10:39 ET | 278 | 267.5 |
| 10:42 ET | 5387 | 266.695 |
| 10:44 ET | 200 | 266.41 |
| 10:48 ET | 741 | 266.52 |
| 10:50 ET | 200 | 266.74 |
| 10:53 ET | 300 | 266.8 |
| 10:55 ET | 1000 | 267.0684 |
| 10:57 ET | 378 | 266.94 |
| 11:00 ET | 200 | 267.32 |
| 11:02 ET | 2022 | 267.09 |
| 11:04 ET | 600 | 266.65 |
| 11:06 ET | 200 | 266.67 |
| 11:08 ET | 1090 | 266.76 |
| 11:09 ET | 100 | 266.88 |
| 11:11 ET | 100 | 266.68 |
| 11:13 ET | 700 | 266.86 |
| 11:15 ET | 1370 | 267.15 |
| 11:18 ET | 4150 | 266.42 |
| 11:20 ET | 2263 | 267.315 |
| 11:22 ET | 100 | 267.255 |
| 11:26 ET | 100 | 267.15 |
| 11:27 ET | 600 | 266.605 |
| 11:29 ET | 300 | 265.66 |
| 11:31 ET | 272 | 265.87 |
| 11:38 ET | 1300 | 265.29 |
| 11:40 ET | 1730 | 265.87 |
| 11:42 ET | 100 | 265.89 |
| 11:44 ET | 400 | 265.62 |
| 11:45 ET | 100 | 265.43 |
| 11:49 ET | 572 | 265.15 |
| 11:51 ET | 582 | 265.43 |
| 11:54 ET | 200 | 266.01 |
| 11:56 ET | 699 | 265.37 |
| 12:00 ET | 907 | 265.4 |
| 12:03 ET | 700 | 265.16 |
| 12:05 ET | 300 | 265.06 |
| 12:07 ET | 200 | 265.13 |
| 12:09 ET | 957 | 264.815 |
| 12:14 ET | 482 | 264.85 |
| 12:16 ET | 100 | 265.09 |
| 12:18 ET | 300 | 265.32 |
| 12:20 ET | 700 | 265.3 |
| 12:21 ET | 200 | 265.36 |
| 12:23 ET | 100 | 265.23 |
| 12:25 ET | 500 | 264.99 |
| 12:27 ET | 3534 | 265.31 |
| 12:30 ET | 200 | 265.29 |
| 12:32 ET | 359 | 265.23 |
| 12:36 ET | 1316 | 265.69 |
| 12:38 ET | 700 | 265.58 |
| 12:39 ET | 1315 | 265.08 |
| 12:41 ET | 200 | 265.36 |
| 12:43 ET | 394 | 265.43 |
| 12:45 ET | 500 | 265.73 |
| 12:48 ET | 100 | 265.83 |
| 12:50 ET | 721 | 265.84 |
| 12:52 ET | 686 | 265.48 |
| 12:54 ET | 122 | 265.25 |
| 12:56 ET | 722 | 265.84 |
| 12:57 ET | 200 | 265.99 |
| 12:59 ET | 100 | 265.92 |
| 01:06 ET | 388 | 265.87 |
| 01:08 ET | 100 | 266.06 |
| 01:10 ET | 2319 | 265.83 |
| 01:12 ET | 769 | 265.84 |
| 01:14 ET | 100 | 265.82 |
| 01:17 ET | 100 | 265.77 |
| 01:21 ET | 700 | 264.77 |
| 01:24 ET | 1625 | 264.27 |
| 01:28 ET | 286 | 264.54 |
| 01:30 ET | 100 | 264.38 |
| 01:32 ET | 100 | 264.37 |
| 01:33 ET | 100 | 264.27 |
| 01:35 ET | 539 | 264.36 |
| 01:37 ET | 100 | 264.36 |
| 01:39 ET | 100 | 264.39 |
| 01:42 ET | 1590 | 264.56 |
| 01:50 ET | 200 | 264.56 |
| 01:51 ET | 200 | 264.56 |
| 01:53 ET | 630 | 264.65 |
| 01:57 ET | 100 | 264.63 |
| 02:00 ET | 400 | 264.85 |
| 02:04 ET | 1579 | 264.67 |
| 02:06 ET | 100 | 264.57 |
| 02:11 ET | 200 | 264.67 |
| 02:13 ET | 100 | 264.66 |
| 02:15 ET | 821 | 264.585 |
| 02:20 ET | 200 | 264.655 |
| 02:26 ET | 2016 | 265.33 |
| 02:29 ET | 100 | 265.28 |
| 02:31 ET | 200 | 265.13 |
| 02:33 ET | 250 | 265.13 |
| 02:36 ET | 400 | 265.13 |
| 02:40 ET | 100 | 265.16 |
| 02:44 ET | 1793 | 265.25 |
| 02:45 ET | 3075 | 264.63 |
| 02:49 ET | 678 | 264.54 |
| 02:51 ET | 100 | 264.55 |
| 02:54 ET | 100 | 264.53 |
| 02:58 ET | 258 | 264.67 |
| 03:02 ET | 100 | 264.645 |
| 03:03 ET | 866 | 264.64 |
| 03:07 ET | 100 | 264.57 |
| 03:09 ET | 757 | 264.75 |
| 03:12 ET | 100 | 264.735 |
| 03:14 ET | 1000 | 264.75 |
| 03:16 ET | 809 | 264.88 |
| 03:18 ET | 159 | 264.88 |
| 03:20 ET | 100 | 264.915 |
| 03:21 ET | 508 | 264.91 |
| 03:23 ET | 710 | 264.985 |
| 03:25 ET | 800 | 264.99 |
| 03:27 ET | 100 | 264.97 |
| 03:30 ET | 3205 | 264.47 |
| 03:32 ET | 835 | 264.56 |
| 03:38 ET | 306 | 264.41 |
| 03:39 ET | 411 | 264.16 |
| 03:41 ET | 2474 | 264.0659 |
| 03:43 ET | 800 | 264.225 |
| 03:45 ET | 2030 | 264.34 |
| 03:48 ET | 607 | 264.3 |
| 03:50 ET | 2379 | 264.19 |
| 03:52 ET | 3335 | 264.47 |
| 03:54 ET | 1978 | 264.67 |
| 03:56 ET | 6889 | 264.56 |
| 03:57 ET | 3892 | 264.41 |
| 03:59 ET | 4154 | 264.27 |
May 3, 2024
DJ United Therapeutics Is Maintained at Neutral by Goldman Sachs, from 12:13PM ET on Friday May 03, 2024 by Dow Jones
12:13PM ET on Friday May 03, 2024 by Dow Jones
May 2, 2024
DJ United Therapeutics Is Maintained at Outperform by Oppenheimer, from 9:10AM ET on Thursday May 02, 2024 by Dow Jones
9:10AM ET on Thursday May 02, 2024 by Dow JonesDJ United Therapeutics Price Target Maintained With a $300.00/Share by HC Wainwright & Co., from 7:07AM ET on Thursday May 02, 2024 by Dow Jones
7:07AM ET on Thursday May 02, 2024 by Dow Jones
May 1, 2024
DJ United Therapeutics Up Over 8%, on Pace for Largest Percent Increase Since November 2022 -- Data Talk, from 2:56PM ET on Wednesday May 01, 2024 by Dow Jones
2:56PM ET on Wednesday May 01, 2024 by Dow JonesUnited Therapeutics Corporation Reports First Quarter 2024 Financial Results, from 6:30AM ET on Wednesday May 01, 2024 by Dow Jones
6:30AM ET on Wednesday May 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
United Therapeutics Corp | 11.8B | 12.5x | +8.22% |
Exact Sciences Corp | 10.0B | -40.4x | --- |
Medpace Holdings Inc | 12.4B | 39.8x | +35.10% |
Biomarin Pharmaceutical Inc | 15.5B | 76.7x | --- |
Qiagen NV | 9.7B | 28.6x | +12.66% |
Neurocrine Biosciences Inc | 14.1B | 37.6x | +62.04% |
Company Information
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Contact Information
- Headquarters
- 1000 SPRING STSILVER SPRING, MD, United States 20910
- Phone
- 301-608-9292
- Fax
- 301-608-9291
Executives
- Chairman of the Board, Chief Executive Officer
- Martine Rothblatt
- President, Chief Operating Officer
- Michael Benkowitz
- Lead Independent Vice Chairman of the Board
- Christopher Patusky
- Chief Financial Officer, Treasurer
- James Edgemond
- Executive Vice President, General Counsel, Corporate Secretary
- Paul Mahon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.8B |
|---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 44.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.48 |
EPS | $21.13 |
Book Value | $127.23 |
P/E Ratio | 12.5x |
Price/Sales (TTM) | 4.7 |
Price/Cash Flow (TTM) | 10.7x |
Operating Margin | 50.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
